1 active not recruiting, 1 recruiting, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Recruiting 1, Unknown 1 |
Follow MASLD: new trials by email Literature Review of MASLD trials Research Report on MASLD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Digoxin In NASH (CODIN) Digoxin, Placebo - NASH, NAFLD | Phase 2 | Recruiting | Yale University | 144 | 2025-06-05 | 2026-05-26 |
| Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects DR10624 Injection, Placebo - MASLD | Phase 2 | Active not recruiting | Zhejiang Doer Biologics Co., Ltd. | 110 | 2025-04-22 | 2026-07-07 |
| Luminal Fructose Kinetics (MARTINI Study) Omeprazole 40 MG - MASLD | Phase 2 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 22 | 2024-07-01 | 2024-08-06 |
Non-alcoholic Fatty Liver Disease (2) · Liver Cirrhosis (1)
Digestive System Diseases (2) · Fatty Liver (2) · Liver Diseases (2) · Fibrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Digoxin (1) · Omeprazole (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Yale University (1) · Zhejiang Doer Biologics Co., Ltd. (1)
China (1) · Hong Kong (1) · Netherlands (1) · United States (1)
Bubu A Banini, MD, PhD (1) · Junping Shi, M.D. (1) · Max Nieuwdorp, prof (1) · Vincent Wai-Sun Wong, M.D. (1)
R01DK134624 (1)